TRAIL-mediated signaling in prostate, bladder and renal cancer.
about
Blocking TRAIL-DR5 signaling with soluble DR5 alleviates acute kidney injury in a severely burned mouse model.Upregulation of microRNA135a-3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis.The Histone Deacetylase Inhibitor Trichostatin A Sensitizes Human Renal Carcinoma Cells to TRAIL-Induced Apoptosis through Down-Regulation of c-FLIPL.Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles.The role of c-FLIP splice variants in urothelial tumours.STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death.Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5Effect of proline rich 15-deficiency on trophoblast viability and survival.Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors.Broad targeting of resistance to apoptosis in cancer.Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells.Mix to validate: a facile, reversible PEGylation for fast screening of potential therapeutic proteins in vivo.Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer.Artepillin C (3,5-diprenyl-4-hydroxycinnamic acid) sensitizes LNCaP prostate cancer cells to TRAIL-induced apoptosisAW00179 potentiates TRAIL-mediated death of human lung cancer H1299 cells through ROS-JNK-c-Jun-mediated up-regulation of DR5 and down-regulation of anti-apoptotic molecules.Polyphenols Isolated from Propolis Augment TRAIL-Induced Apoptosis in Cancer Cells.Milk disrupts p53 and DNMT1, the guardians of the genome: implications for acne vulgaris and prostate cancer.Cell death-based approaches in treatment of the urinary tract-associated diseases: a fight for survival in the killing fields.Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway.
P2860
Q33898510-5B530917-8954-42D5-95B6-90EEC4CD6360Q34221779-6FAB80C9-B038-4073-87F3-950B39688912Q34865077-F7590E8E-29DA-4255-8450-37C557DE9915Q35201530-A3DA5408-552C-4F22-865C-C6C7B0DF9194Q35657114-9D6C961D-9AC8-42F8-B412-174AD9EEE58EQ35946035-FD14DB2E-8B18-4B1B-B526-984046519B39Q36300065-F260392B-64F1-4169-A609-3D4222DB64B0Q36336018-392B6504-4808-4D67-9B09-4E791BC06B6DQ36395984-434F1224-6A58-4EF5-9100-177E2D1470B3Q36483749-70887844-6599-4FF1-8C10-F5AF19554FDAQ37029804-48ED3FEF-4B5E-4838-9486-4D091A50E04FQ37517140-188F2830-EA54-4D15-8C6A-A8416F4940CDQ39264067-3E49AD00-4BA8-443E-BC29-92FC1700C537Q39324841-0D18F5FA-873C-477B-9400-B7B4254E2CA5Q39392672-68F322C5-DAA1-417E-9868-C88157F46517Q39558311-085EC649-12A3-4115-A0C2-1CB193155DD5Q41396848-2534FFC4-9416-48EC-9BC6-9F6B67AAAA6CQ47711163-E0AB98F1-5665-4077-906E-E693FE8AECD9Q52877003-E63F8075-6C86-49E0-BEBD-B56B244CC8EB
P2860
TRAIL-mediated signaling in prostate, bladder and renal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TRAIL-mediated signaling in prostate, bladder and renal cancer.
@en
TRAIL-mediated signaling in prostate, bladder and renal cancer.
@nl
type
label
TRAIL-mediated signaling in prostate, bladder and renal cancer.
@en
TRAIL-mediated signaling in prostate, bladder and renal cancer.
@nl
prefLabel
TRAIL-mediated signaling in prostate, bladder and renal cancer.
@en
TRAIL-mediated signaling in prostate, bladder and renal cancer.
@nl
P2860
P356
P1476
TRAIL-mediated signaling in prostate, bladder and renal cancer.
@en
P2093
Christina Voelkel-Johnson
P2860
P2888
P304
P356
10.1038/NRUROL.2011.81
P407
P577
2011-06-14T00:00:00Z